Literature DB >> 7629297

Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis.

P E Verweij1, A J Rijs, B E De Pauw, A M Horrevorts, J A Hoogkamp-Korstanje, J F Meis.   

Abstract

AIMS: The performance of the Pastorex Aspergillus antigen latex agglutination test for the detection of galactomannan in sera of patients at risk for invasive aspergillosis was evaluated, and the impact of storage on the reproducibility of the antigen titre was tested.
METHODS: During a one year period, 392 serum samples were obtained from 46 patients at risk for invasive aspergillosis and tested for the presence of galactomannan using an Aspergillus latex agglutination test (Pastorex). Twenty three positive serum samples which had been stored at -20 degrees C for 2-16 months were retrospectively retested. Furthermore, two positive serum samples were stored at -20 degrees C and -70 degrees C and prospectively tested at three month intervals for a period of 15 months.
RESULTS: The Pastorex Aspergillus test was positive in eight patients with microbiological, radiological, or histological evidence for invasive aspergillosis, but was negative in the initial serum sample from five of these patients. In two patients with histological evidence for invasive aspergillosis no positive reaction was found in six samples. Six of 13 (45%) serum samples which had been stored at -20 degrees C for longer than six months had lost reactivity, while one of 10 (10%) samples had lost reactivity when stored up to six months. Two serum samples which had been stored at -20 degrees C and -70 degrees C and prospectively retested at three month intervals for 15 months, maintained stable antigen titres.
CONCLUSIONS: The Pastorex Aspergillus test is too insensitive to diagnose invasive aspergillosis in an early stage, but may contribute to the diagnosis when cultures remain negative and serial samples are obtained. To maintain a good reproducibility, serum samples should be stored at -70 degrees C when the period of storage exceeds six months.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629297      PMCID: PMC502628          DOI: 10.1136/jcp.48.5.474

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Aspergillus antigen latex test for diagnosis of invasive aspergillosis.

Authors:  D W Warnock; A B Foot; E M Johnson; S B Mitchell; J M Cornish; A Oakhill
Journal:  Lancet       Date:  1991-10-19       Impact factor: 79.321

2.  Serodiagnosis of invasive aspergillosis in patients with hematologic malignancy: validation of the Aspergillus fumigatus antigen radioimmunoassay.

Authors:  G H Talbot; M H Weiner; S L Gerson; M Provencher; S Hurwitz
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

3.  Specific amplification of Aspergillus fumigatus DNA by polymerase chain reaction.

Authors:  L V Reddy; A Kumar; V P Kurup
Journal:  Mol Cell Probes       Date:  1993-04       Impact factor: 2.365

4.  The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen.

Authors:  J R Sabetta; P Miniter; V T Andriole
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

5.  Rat monoclonal antibodies against Aspergillus galactomannan.

Authors:  D Stynen; J Sarfati; A Goris; M C Prévost; M Lesourd; H Kamphuis; V Darras; J P Latgé
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

6.  Detection of Aspergillus fumigatus by polymerase chain reaction.

Authors:  C Spreadbury; D Holden; A Aufauvre-Brown; B Bainbridge; J Cohen
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

7.  Retrospective evaluation of a latex agglutination test for diagnosis of invasive aspergillosis in immunocompromised patients.

Authors:  K Haynes; T R Rogers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

8.  Antigen detection in the diagnosis of invasive aspergillosis. Utility in controlled, blinded trials.

Authors:  M H Weiner; G H Talbot; S L Gerson; G Filice; P A Cassileth
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

Review 9.  Immunodiagnosis of aspergillosis.

Authors:  V P Kurup; A Kumar
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

10.  Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response.

Authors:  J Aisner; P H Wiernik; S C Schimpff
Journal:  Ann Intern Med       Date:  1977-05       Impact factor: 25.391

View more
  13 in total

1.  Aspergillus antigen testing in bone marrow transplant recipients.

Authors:  E C Williamson; D A Oliver; E M Johnson; A B Foot; D I Marks; D W Warnock
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

2.  Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan.

Authors:  C M Swanink; J F Meis; A J Rijs; J P Donnelly; P E Verweij
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples.

Authors:  P E Verweij; E C Dompeling; J P Donnelly; A V Schattenberg; J F Meis
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

4.  Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies.

Authors:  P E Verweij; J P Latgé; A J Rijs; W J Melchers; B E De Pauw; J A Hoogkamp-Korstanje; J F Meis
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

5.  Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients.

Authors:  P E Verweij; D Stynen; A J Rijs; B E de Pauw; J A Hoogkamp-Korstanje; J F Meis
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

6.  Comparison of commercial latex agglutination and sandwich enzyme immunoassays with a competitive binding inhibition enzyme immunoassay for detection of antigenemia and antigenuria in a rabbit model of invasive aspergillosis.

Authors:  S F Hurst; G H Reyes; D W McLaughlin; E Reiss; C J Morrison
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

7.  Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR.

Authors:  H Skladny; D Buchheidt; C Baust; F Krieg-Schneider; W Seifarth; C Leib-Mösch; R Hehlmann
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

8.  A polymerase chain reaction enzyme immunoassay for diagnosing infection caused by Aspergillus fumigatus.

Authors:  N Golbang; J P Burnie; R C Matthews
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

9.  Detection of antigen in sera of patients with invasive aspergillosis: intra- and interlaboratory reproducibility. The Dutch Interuniversity Working Party for Invasive Mycoses.

Authors:  P E Verweij; Z Erjavec; W Sluiters; W Goessens; M Rozenberg-Arska; Y J Debets-Ossenkopp; H F Guiot; J F Meis
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

Review 10.  Invasive aspergillosis caused by Aspergillus ustus: case report and review.

Authors:  P E Verweij; M F van den Bergh; P M Rath; B E de Pauw; A Voss; J F Meis
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.